Cancer Institute and Hospital, Chinese Academy of Medical Sciences: all 387 studies

Page 3 of 4. Open to participants first (275), then studies with results posted, then the rest; newest registration first within each.

• Real-world Clinical Outcomes of NSCLC Patients Receiving Neoadjuvant ImmunotherapyRecruitingNCT06317558
• Quantitative Evaluation of the Impact of Relaxing Eligibility Criteria for Lung Cancer Based on Real-world DataRecruitingNCT06314542
• The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung CancerRecruitingNCT06287320
• 68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTCRecruitingNCT06277180Not applicable
• Clinical Trial for Advanced or Metastatic Pancreatic CancerNot yet recruitingNCT06255912Phase 2
• Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung CancersRecruitingNCT06255197
• Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer TrialNot yet recruitingNCT06245824Phase 4
• Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast CancerNot yet recruitingNCT06229067Phase 2
• Multi-omics Analysis to Characterize the Invasive Evolution of Pulmonary Subsolid NodulesRecruitingNCT06215885
• Phase II Study of Adjuvant SIB Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.RecruitingNCT06205472Phase 2
• Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPCRecruitingNCT06202014Phase 2
• Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC PatientsRecruitingNCT06202001Phase 1/2
• Golidocitinib in Combination With Sintilimab for PD-L1 Selected Treatment Locally Advanced or Metastatic Non-Small Cell Lung Cancer(NSCLC)Not yet recruitingNCT06198907Phase 2
• Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast CancerRecruitingNCT06197581Not applicable
• RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 AlterationsNot yet recruitingNCT06185400Phase 2
• Postoperative CCRT Followed by Immunotherapy in High-Risk LA HNSCCRecruitingNCT06170710Phase 2
• Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell CarcinomaRecruitingNCT06170697Phase 2
• Camrelizumab Combined With Chemotherapy and Radiotherapy Perioperative Treatment of Esophageal Gastric Junction AdenocarcinomaRecruitingNCT06163729Phase 2
• Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal CancerRecruitingNCT06154538Phase 2
• Personalized KSX01-TCRT in Patients With Advanced Solid TumorsRecruitingNCT06150365Early Phase 1
• Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer PatientsNot yet recruitingNCT06149533Phase 3
• Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)RecruitingNCT06146946Not applicable
• Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal CancerRecruitingNCT06135571
• Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal CancerRecruitingNCT06114420
• Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid CarcinomaRecruitingNCT06087068Phase 2
• PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal CancerRecruitingNCT06086457Phase 3
• Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus ChemotherapyRecruitingNCT06084897Phase 2
• 68Ga-TCR-FAPI PET/CT in Patients With Various Types of CancerRecruitingNCT06084767Not applicable
• A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor PatientsNot yet recruitingNCT06082570Phase 1/2
• A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor PatientsNot yet recruitingNCT06082557Phase 1/2
• A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid CancerRecruitingNCT06082180Phase 3
• A Study of RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder CancerRecruitingNCT06074484Phase 2
• NV-001 in the Treatment of Advanced Solid TumorsRecruitingNCT06051760Phase 1
• An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine TumorsRecruitingNCT06038461Phase 1/2
• Applications of Fluorescence Imaging Guided Lymph Node Dissection and Fluorescence Angiography of Inferior Mesenteric Artery Assisted Left Colic Artery PreservationRecruitingNCT06033794Not applicable
• The Sequential Combination of FOLFOX and Toripalimab for Perioperative Immuno-Oncology Therapy of HER2-negative Adenocarcinoma of the Esophagogastric Junction (Siewert I/II):Not yet recruitingNCT05986227Phase 1/2
• Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast CancerRecruitingNCT05983107Phase 2
• Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast CancerNot yet recruitingNCT05983094Phase 2
• Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLCRecruitingNCT05974007
• XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRCRecruitingNCT05970302Phase 2
• Safety and Feasibility of Laparoscopic Intracorporeal Anastomosis for Colorectal Surgery- A Multiple Center Real World StudyRecruitingNCT05911152
• The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLCNot yet recruitingNCT05904015Phase 2
• LK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung CancerRecruitingNCT05886439Phase 1/2
• XELOX Combined With Cadonilimab Versus XELOX as Neoadjuvant Treatment for Locally Advanced, pMMR Rectal CancerRecruitingNCT05815303Phase 2
• Cadonilimab in Locally Advanced MSI-H/dMMR Colorectal CancerRecruitingNCT05815290Phase 2
• MSLN-targeted CAR-T Cells in Solid Tumors.Not yet recruitingNCT05783089Phase 1
• Postoperative Management for HNSCC Based on Pathological Response of Induction Chemotherapy and ImmunotherapyRecruitingNCT05777824Phase 2
• Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer PatientsRecruitingNCT05762900Phase 2
• Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive TumorRecruitingNCT05761366Phase 2
• Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated ProteinsRecruitingNCT05749302Phase 2/3
• Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR ExpressionRecruitingNCT05749289Phase 2/3
• Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon CancerNot yet recruitingNCT05730595Not applicable
• Deep Learning-based Classification and Prediction of Radiation Dermatitis in Head and Neck PatientsRecruitingNCT05607225
• A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN)RecruitingNCT05603078Not applicable
• Early Screening of Colorectal Cancer Based on Plasma Multi-omics Combining With Artificial IntelligenceRecruitingNCT05587452
• Perioperative Analgesia Modes in Minimally Invasive EsophagectomyRecruitingNCT05504265Phase 2/3
• Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal CarcinomaRecruitingNCT05448885Phase 2
• Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC PatientsRecruitingNCT05443646Phase 2
• The Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive / HER2-negative Advanced Breast Cancer Patients With Visceral CrisisNot yet recruitingNCT05431504Phase 2
• Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal CarcinomaRecruitingNCT05385926Phase 2
• Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast CancerRecruitingNCT05345860Not applicable
• Surgery or Chemoradiotherapy for Cervical Esophageal CancerRecruitingNCT05327517Not applicable
• Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01)RecruitingNCT05224934Not applicable
• First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural MesotheliomaRecruitingNCT05188859Phase 2
• MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)RecruitingNCT05183074Not applicable
• Preoperative IMRT With Anlotinib and Penpulimab for Localized Sarcoma （SPARE-01）RecruitingNCT05167994Phase 2
• MRI-guided Lateral Lymph Node Dissection in Rectal CancerRecruitingNCT04850027
• Neoadjuvant Treatment Modalities in Esophageal CancerRecruitingNCT04821843Phase 3
• Chemoradiotherapy in Esophageal or Esophagogastric Junction CancerRecruitingNCT04821778Phase 3
• Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung CancerNot yet recruitingNCT04506242Phase 2
• PLATFORM Study of Precision Medicine for Rare TumorsRecruitingNCT04423185Phase 2
• Chemoradiotherapy in Unresectable Esophageal CancerRecruitingNCT04278287Phase 1/2
• MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal CancerRecruitingNCT03714490Phase 2
• MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing ChemoradiotherapyRecruitingNCT02988921Not applicable
• Safety Study of Totally Laparoscopic Resection With Natural Orifice Specimen Extraction (NOSE) for Rectosigmoid CancerRecruitingNCT02635503Phase 3
• Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical ResectionCompletedNCT03575806Phase 2Results posted
• Chaigui Jieyu Qufa Decoction for CRF in Driver Gene-negative Lung Adenocarcinoma TrialCompletedNCT07890051Not applicable
• Radiotherapy Target Volume in Locally Advanced Esophageal Squamous Cell Carcinoma in the Immunotherapy EraActive, not recruitingNCT07879898
• Induction Chemoimmunotherapy Followed by Deescalated Definitive Radiotherapy in Head and Neck CancerActive, not recruitingNCT07791602Phase 2
• Microfluidic Urinary Exosome-Based Diagnostic Model for Bladder CancerActive, not recruitingNCT07735858
• Impact of Anterior Urethral Suspension Combined With Pelvic Fascia Reconstruction During Robot-Assisted Radical Prostatectomy on Early Postoperative Urinary Continence Recovery: A Single-Center, Prospective, Single-Arm Clinical StudyCompletedNCT07725653Not applicable
• Bevacizumab Plus Nab-paclitaxel and Tegafur Gimeracil Oteracil Potassium Capsule (S-1) as Second-line Treatment for Advanced Biliary Tract Cancer: a Phase Ⅱ Clinical TrialCompletedNCT07719738Phase 2
• Phase II Study of Induction Chemoimmunotherapy Followed by Radiotherapy and Organ Preservation in Resectable ESCCActive, not recruitingNCT07711470Phase 2
• Treatment of Orelabrutinib+Hi-CVP Regimen for Previously Untreated MZLActive, not recruitingNCT07480863Phase 2
• Efficacy and Safety of Glofitamab Combined With GemOxin the Treatment of Refractory Diffuse Large B-Cell LymphomaActive, not recruitingNCT07480850Phase 2
• Dynamic Monitoring of Plasma ctDNA for Prognostic Assessment in Patients With B-Cell Non-Hodgkin LymphomaActive, not recruitingNCT07480837
• The Factors Influencing the Success of Redo Surgery and Anal Function for Anastomosis Failure or Local Tumor RecurrenceCompletedNCT07440888
• Efficacy and Survival Analysis of Perioperative Treatment of Locally Advanced Gastric or Gastroesophageal Junction CancerActive, not recruitingNCT07429318
• Fractionated Stereotactic Radiotherapy for Limited Small Volume Brain MetastasesCompletedNCT07405047Not applicable
• A Multicenter Study on the Safety and Functionality Evaluation of Anastomotic Redo SurgeryCompletedNCT07279961
• Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant ImmunotherapyActive, not recruitingNCT07256002
• Efficacy and Safety of XTD Regimen (Selinexor, Thalidomide and Dexamethasone) in Adult Patients With Relapsed/Refractory LCHActive, not recruitingNCT07204041Phase 2
• Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLCCompletedNCT07186855
• Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell CarcinomaActive, not recruitingNCT07147361
• Prophylactic PEG-rhG-CSF During cCRT in LA-NSCLCCompletedNCT06958614
• Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended LymphadenectomyCompletedNCT06820320Phase 2
• Nimotuzumab High-risk, Locally Advanced Squamous Cell Carcinoma of the CervixActive, not recruitingNCT06771596Phase 2
• The Impact of Inflammatory Adhesion on the Prognosis of Colon Cancer PatientsCompletedNCT06655285
• Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain MetastasesActive, not recruitingNCT06611657Phase 2
• Clinical Study of QH104 Cell Injection for the Treatment of Meningeal Metastases of B7H3+ Solid TumorsCompletedNCT06592092Not applicable

← Cancer Institute and Hospital, Chinese Academy of Medical Sciences overview and focus areas